Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) is a publicly traded Healthcare sector company. As of October 13, 2026, RANI trades at $0.74 with a market cap of $86.67M and a P/E ratio of -1.84. RANI moved -3.02% today. Year to date, RANI is -46.09%; over the trailing twelve months it is +56.50%. Its 52-week range spans $0.39 to $3.87. Analyst consensus is strong buy with an average price target of $6.75. Rallies surfaces RANI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for RANI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $86.67M |
| P/E Ratio | -1.84 |
| EPS | $-0.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.87 |
| 52-Week Low | $0.39 |
| Volume | 891.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.63M |
| Net Income | $-40.95M |
| Gross Margin | 0.00% |
4 analysts cover RANI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.75.